Immune checkpoint inhibitors advance melanoma treatmentWhile much progress has been made since interleukin-2 was used to treat melanoma, physicians are still weighing the advantages and disadvantages of monotherapy versus combination therapies.
Disruptive technologies expand NMSC tx optionsMinimally invasive radiation therapy techniques may be viable alternatives for treatment of non-melanoma skin cancers in a variety of situations.